Summary
Forskolin is a unique activator of adenylate cyclase that bypasses membrane receptors and directly raises levels of the second messenger cyclic AMP. Depressed patients and schizophrenic patients with negative symptoms have been reported to have reduced cyclic AMP levels. In the first study of forskolin in psychiatry, we gave iv forskolin in a 75 minute infusion to four depressed and five schizophrenic patients. All four depressed patients showed a transient mood elevation or stimulation, as did two of the five schizophrenic patients.
This is a preview of subscription content, log in via an institution to check access.
References
Baumann G, Felix S, Sattelberger U, Klein G (1990) Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy — a comparative study with dobutamine and sodium nitroprusside. J Cardiovasc Pharmacol 16: 93–100
Belmaker RH (1981) Receptors, adenylate cyclase, depression and lithium. Biol Psychiatry 16: 333–350
Belmaker RH, Zohar J, Ebstein RP (1980) Cyclic nucleotides in mental disorder. Adv Cyclic Nucl Res 12: 187–198
Belmaker RH, Stein D, Weinberger D, Potkin SG, Wyatt RJ (1984) Cerebrospinal fluid cyclic nucleotides in schizophrenia. Clin Neuropharmacol 7: 173–178
Brown BL, Salway JG, Albans JMD, Hullin P, Ekins RP (1972) Urinary excretion of cyclic AMP and manic-depressive psychosis. Br J Psychiatry 120: 405–408
Kaplan Z, Schreiber G, Belmaker RH (1988) Lack of effectiveness of forskolin or inositol as antidote in lithium toxicity. J Neural Transm 72: 167–170
Marone G, Petracca R, Vigorita S, Casolaro V (1990) Adenosine receptors of human leukocytes. II. Characterization of an inhibitory P-site. Biochem Pharmacol 40: 1963–1973
Metzger H, Lindner E (1981) The positive inotropic forskolin, a potent adenylate cyclase activator. Drug Res 31: 1248–1250
Morita T, Wheeler MA, Weiss RM (1986) Relaxant effect of forskolin in rabbit detrusor smooth muscle: role of cyclic AMP. J Urol 135: 1293–1295
Patishi Y, Jensen JB, Mork A, Bersudsky Y, Belmaker RH (1996) The effect of acute and chronic lithium on forskolin-induced reduction of rat activity (submitted)
Seamon KB, Padgett W, Daly JW (1981) Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78: 3363–3367
Tece JJ, Cole JO (1974) Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain activity (CNV). Science 185: 451–453
Wachtel H (1989) Dysbalance of neural second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors. J Neural Transm 75: 21–29
Wachtel H, Leschmann PA (1986) Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram. Psychopharmacology 90: 430–435
Wachtel H, Löschmann P-A, Schneider HH, Rettig K-J (1987) Effects of forskolin on spontaneous behavior, rectal temperature and brain cAMP levels of rats: interaction with rolipram. Neurosci Lett 76: 191–196
Zohar J, Rimon R, Biederman J, Ebstein RP, Belmaker RH (1978) Clinical correlates of CSF cyclic nucleotides in schizophrenia. Am J Psychiatry 135: 253–25
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bersudsky, Y., Kotler, M., Shifrin, M. et al. A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. J. Neural Transmission 103, 1463–1467 (1996). https://doi.org/10.1007/BF01271261
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271261